Value through Innovation

main navigation

jump to content to meta navigation
Cardiovascular Disease News & Information

page content

jump to main navigation to meta navigation

Cardiovascular Disease (CVD) News and Information

This section includes information and resources about Cardiovascular Disease for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Cardiovascular Disease Press Releases

14.06.2010 Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010 - For Medical Media Only
27.11.2009 Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients - For medical media, outside the US only
19.10.2009 FDA approves Micardis® (telmisartan) as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors - For medical media, outside the US only
back to top

Media Contact

Media Contact
Our media contacts

Other News & Press Releases

boehringer-ingelheim.com

Boehringer Ingelheim offers an optimized solution for mobile devices
Solution for mobile devices

News & Press Releases

News